Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
29 participants
INTERVENTIONAL
2013-12-31
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dim light
15 minutes of very dim (\<1 lux) light during the night
Light
Room light
15 minutes of normal room light (\~100 lux) during the night
Light
Colored light
15 minutes of colored light during the night
Light
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Light
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 20/200 corrected visual acuity
* Greater than 20° visual field with no lower visual field loss
* Stable health
* Male or female
* Normal color vision
* Normal hearing
Exclusion Criteria
* Sleep disorders
* Dementia
* Smoker
* Depression
* Alcohol abuse
* Use of illegal drugs
* Use of sleep/wake altering drugs on an acute or as needed basis (including nutraceuticals, antihistamines)
* Use of light sensitizing drugs
* Self-reported history of nocturia (\>3 times per night)
55 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
VA Palo Alto Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie M. Zeitzer, Ph.D.
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Palo Alto Health Care System
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.